Additionally, METTL3 is upregulated in chemotherapy-resistant AML cells, where it contributes to resistance by promoting bone marrow homing and engraftment through upregulation of ITGA4 [24]. This evidence concerns the gene METTL3 and acute myeloid leukemia.